© GettyImages/Pheelings Media

FDA rebuff for Keytruda in breast cancer indication

By Jane Byrne

A couple of new developments to report in relation to Merck, known as MSD outside the US and Canada: the first being the rejection by the US FDA of the company’s application to use its anti-PD-1 therapy, Keytruda, in certain breast cancer patients.

(seb_ra/iStock via Getty Images Plus)

People on the Move: February 2021

By Jenni Spinner

This month’s announcements about industry hires, promotions, alliances and other important events includes Merck, Lonza, Medable and other key firms.

(olegback/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.


Follow us


View more


Featured Suppliers